臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"yu c j"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 1611-1635 / 2308 (共93頁)
<< < 60 61 62 63 64 65 66 67 68 69 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2020-05-26T09:27:23Z	Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response	Yang P.-C.;Shin J.-Y;Yu C.-J;Chang Y.-L;Gow C.-H;Chih-Hsin Yang;Wu S.-G;Wu J.-Y; Wu J.-Y; Wu S.-G; CHIH-HSIN YANG; Gow C.-H; Chang Y.-L; Yu C.-J; Shin J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:23Z	Predictors of toxicity of weekly docetaxel in chemotherapy-treated non-small cell lung cancers	Chih-Hsin Yang;Shih J.-Y;Hsu C;Yu C.-J;Lo Y;Chen J.-P; Chen J.-P; Lo Y; Yu C.-J; Hsu C; Shih J.-Y; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:27:22Z	Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma	Shih J.-Y; Lee Y.-C; Yang P.-C.; Yang P.-C.;Lee Y.-C;Shih J.-Y;Hsu Y.-C;Chih-Hsin Yang;Chang Y.-L;Yu C.-J;Gow C.-H;Wu S.-G; Wu S.-G; Gow C.-H; Yu C.-J; Chang Y.-L; CHIH-HSIN YANG; Hsu Y.-C
臺大學術典藏	2020-05-26T09:27:22Z	High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy	Kao W.-Y.;Lin Z.-Z;Yu C.-T;Kuo H.-P;Chang W.-C;Yu C.-J;Chung C.-Y;Ho M.-L;Wang J.-L;Huang M.-S;Chen C.-H;Chen H.-C;Hsia T.-C;Tsao C.-J;Su W.-C;Lai R.-S;Chu N.-M;Hsieh R.-K;Lin M.-C;Chang G.-C;Chen Y.-M;Chih-Hsin Yang;Perng R.-P; Perng R.-P; CHIH-HSIN YANG; Chen Y.-M; Chang G.-C; Lin M.-C; Hsieh R.-K; Chu N.-M; Lai R.-S; Su W.-C; Tsao C.-J; Hsia T.-C; Chen H.-C; Chen C.-H; Huang M.-S; Wang J.-L; Ho M.-L; Chung C.-Y; Yu C.-J; Chang W.-C; Kuo H.-P; Yu C.-T; Lin Z.-Z; Kao W.-Y.
臺大學術典藏	2020-05-26T09:27:22Z	Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy	Yang P.-C.;Pao W;Cheng A.-L;Bean J;Huang C.-L;Shun C.-T;Huang C.-J;Lin Z.-Z;Chen K.-Y;Tsai M.-C;Hu F.-C;Chang Y.-C;Shih J.-Y;Yu C.-J;Chih-Hsin Yang; CHIH-HSIN YANG; Yu C.-J; Shih J.-Y; Chang Y.-C; Hu F.-C; Tsai M.-C; Chen K.-Y; Lin Z.-Z; Huang C.-J; Shun C.-T; Huang C.-L; Bean J; Cheng A.-L; Pao W; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:21Z	Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial	Lin C.-C; Huang T.-C; Yang P.-C; CHIH-HSIN YANG; Yu C.-J; Shih J.-Y; Cheng A.-L; Hu F.-C; Kuo S.-H; Hsu C; Chih-Hsin Yang;Yang P.-C;Huang T.-C;Lin C.-C;Yu C.-J;Shih J.-Y;Cheng A.-L;Hu F.-C;Kuo S.-H;Hsu C
臺大學術典藏	2020-05-26T09:27:21Z	First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer	Yang P.-C.;Shih J.-Y;Wei P.-F;Hsu Y.-C;Chang Y.-C;Gow C.-H;Chiu Y.-H;Wu S.-G;Chih-Hsin Yang;Yu C.-J;Wu J.-Y; Wu J.-Y; Yu C.-J; CHIH-HSIN YANG; Wu S.-G; Chiu Y.-H; Gow C.-H; Chang Y.-C; Hsu Y.-C; Wei P.-F; Shih J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:21Z	Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern	Yang P.-C.;Shih J.-Y;Tsai M.-F;Yu C.-J;Chih-Hsin Yang;Wu J.-Y;Hsu Y.-C;Chang Y.-L;Wu S.-G; Wu S.-G; Chang Y.-L; Hsu Y.-C; Wu J.-Y; CHIH-HSIN YANG; Yu C.-J; Tsai M.-F; Shih J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:19Z	EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment	Huang C.-L; CHIH-HSIN YANG; Yeh K.-H; Hu F.-C; Chen K.-Y; Shih J.-Y; Lin Z.-Z; Yu C.-J; Cheng A.-L; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:19Z	Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer	Gow C.-H; Chang Y.-L; Hsu Y.-C; Tsai M.-F; Wu C.-T; Yu C.-J; CHIH-HSIN YANG; Lee Y.-C; Yang P.-C; Shih J.-Y.
臺大學術典藏	2020-05-26T09:27:18Z	Octogenarians with advanced non-small cell lung cancer: Treatment modalities, survival, and prognostic factors	Yang P.-C.; Yu C.-J; CHIH-HSIN YANG; Shih J.-Y; Chen J.-H; Chen K.-Y; Chen K.-Y;Chen J.-H;Shih J.-Y;Chih-Hsin Yang;Yu C.-J;Yang P.-C.
臺大學術典藏	2020-05-26T09:27:18Z	Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer	Wu J.-Y;Shih J.-Y;Chih-Hsin Yang;Chen K.-Y;Ho C.-C;Yu C.-J;Yang P.-C.; Wu J.-Y; Shih J.-Y; CHIH-HSIN YANG; Chen K.-Y; Ho C.-C; Yu C.-J; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:18Z	Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptors	Lin C.-C;Hsu H.-H;Sun C.-T;Shih J.-Y;Lin Z.-Z;Yu C.-J;Chen G.G;Hsin M.K.Y;Lam K.C;Leung L;Chih-Hsin Yang;Mok T.; Lin C.-C; Hsu H.-H; Sun C.-T; Shih J.-Y; Lin Z.-Z; Yu C.-J; Chen G.G; Hsin M.K.Y; Lam K.C; Leung L; CHIH-HSIN YANG; Mok T.
臺大學術典藏	2020-05-26T09:27:18Z	Pemetrexed for heavily pretreated patients with advanced non-small cell lung cancer	Lee J.-H;Yu C.-J;Chen K.-Y;Shih J.-Y;Lin Y.-L;Chih-Hsin Yang; Lee J.-H; Yu C.-J; Chen K.-Y; Shih J.-Y; Lin Y.-L; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:27:16Z	Use of cetuximab after failure of gefitinib in patients with advanced non-small-cell lung cancer	Shih J.-Y; Chang S.-H; Yu C.-J; Hsu Y.-C; CHIH-HSIN YANG; Wu J.-Y; Wu J.-Y;Chih-Hsin Yang;Hsu Y.-C;Yu C.-J;Chang S.-H;Shih J.-Y;Yang P.-C.; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:16Z	Influence of first-line chemotherapy and EGFR mutations on second-line gefitinib in advanced non-small cell lung cancer	Wu J.-Y;Yu C.-J;Shih J.-Y;Chih-Hsin Yang;Yang P.-C.; Wu J.-Y; Yu C.-J; Shih J.-Y; CHIH-HSIN YANG; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:12Z	Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations	CHIH-HSIN YANG; Yu C.-J; Lee J.-H; Hsu Y.-C; Chang Y.-L; Shih J.-Y; Yang P.-C.; Wu S.-G;Chih-Hsin Yang;Yu C.-J;Lee J.-H;Hsu Y.-C;Chang Y.-L;Shih J.-Y;Yang P.-C.; Wu S.-G
臺大學術典藏	2020-05-26T09:27:12Z	Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations	Wu J.-Y;Shih J.-Y;Chen K.-Y;Chih-Hsin Yang;Yu C.-J;Yang P.-C.; Wu J.-Y; Shih J.-Y; Chen K.-Y; CHIH-HSIN YANG; Yu C.-J; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:12Z	Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer	Wu J.-Y;Yu C.-J;Chang Y.-C;Chih-Hsin Yang;Shih J.-Y;Yang P.-C.; Wu J.-Y; Yu C.-J; Chang Y.-C; CHIH-HSIN YANG; Shih J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:11Z	Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed	Chen C.-Y;Chang Y.-L;Shih J.-Y;Lin J.-W;Chen K.-Y;Chih-Hsin Yang;Yu C.-J;Yang P.-C.; Chen C.-Y; Chang Y.-L; Shih J.-Y; Lin J.-W; Chen K.-Y; CHIH-HSIN YANG; Yu C.-J; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:10Z	EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR	Yang P.-C.;Chih-Hsin Yang;Yu C.-J;Tsai M.-F;Chen Y.-H;Shih J.-Y;Chang Y.-L;Kuo Y.-W;Wu S.-G; Wu S.-G; Kuo Y.-W; Chang Y.-L; Shih J.-Y; Chen Y.-H; Tsai M.-F; Yu C.-J; CHIH-HSIN YANG; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:09Z	Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum	Yu C.-J.;Chen Y.-M;Chih-Hsin Yang;Cheng Y.-K;Chang G.-C;Shih J.-Y;Liao W.-Y; Liao W.-Y; Shih J.-Y; Chang G.-C; Cheng Y.-K; CHIH-HSIN YANG; Chen Y.-M; Yu C.-J.
臺大學術典藏	2020-05-26T09:27:07Z	Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR	Yang P.-C.;Shih J.-Y;Wei P.-F;Yu C.-J;Chih-Hsin Yang;Wu J.-Y;Wu S.-G;Chung K.-P; Chung K.-P; Wu S.-G; Wu J.-Y; CHIH-HSIN YANG; Yu C.-J; Wei P.-F; Shih J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:07Z	Advanced non-small cell lung cancer in patients aged 45 years or younger: Outcomes and prognostic factors	Yang P.-C.;Yu C.-J;Chih-Hsin Yang;Ho C.-C;Shih J.-Y;Chen K.-Y;Hsu C.-L; Hsu C.-L; Chen K.-Y; Shih J.-Y; Ho C.-C; CHIH-HSIN YANG; Yu C.-J; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:07Z	Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): A phase 2 trial	Miller V.A.;Yang P.-C;Lorence R.M;Cong X.J;Shahidi M;Dudek A.Z;Sequist L.V;Ho C.-L;Chang G.-C;Yu C.-J;Ou S.H.I;Tsai C.-M;Hsia T.-C;Su W.-C;Shih J.-Y;Chih-Hsin Yang; CHIH-HSIN YANG; Shih J.-Y; Su W.-C; Hsia T.-C; Tsai C.-M; Ou S.H.I; Yu C.-J; Chang G.-C; Ho C.-L; Sequist L.V; Dudek A.Z; Shahidi M; Cong X.J; Lorence R.M; Yang P.-C; Miller V.A.

顯示項目 1611-1635 / 2308 (共93頁)
<< < 60 61 62 63 64 65 66 67 68 69 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :2856708
	造訪人次 : 53592264 線上人數 : 775 教育部委託研究計畫計畫執行:國立臺灣大學圖書館